Pfizer CRZ 250 (Xalkori 250 mg)
Generic Name: crizotinib
Pill with imprint Pfizer CRZ 250 is Pink, Capsule-shape and has been identified as Xalkori 250 mg. It is supplied by Pfizer Inc.
Xalkori is used in the treatment of non-small cell lung cancer; lymphoma and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer CRZ 250
Xalkori
- Generic Name
- crizotinib
- Imprint
- Pfizer CRZ 250
- Strength
- 250 mg
- Color
- Pink
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-8140
- Inactive Ingredients
-
silicon dioxide,
microcrystalline cellulose,
calcium phosphate dibasic anhydrous,
magnesium stearate,
titanium dioxide,
ferric oxide red,
shellac,
propylene glycol,
ammonia,
potassium hydroxide,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about Xalkori (crizotinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (4)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.